Your browser doesn't support javascript.
loading
Chimeric antigen receptor therapy for T-cell acute lymphoblastic leukemia: finally catching up with B-cell leukemia?
Beyar-Katz, Ofrat; Rowe, Jacob M.
Affiliation
  • Beyar-Katz O; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa. o_katz@rmc.gov.il.
  • Rowe JM; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa; The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology, Haifa; Shaare Zedek Medical Center, Jerusalem.
Haematologica ; 109(6): 1631-1633, 2024 06 01.
Article in En | MEDLINE | ID: mdl-38832419
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Haematologica Year: 2024 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunotherapy, Adoptive / Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Receptors, Chimeric Antigen Limits: Humans Language: En Journal: Haematologica Year: 2024 Document type: Article Country of publication: